Ocugen, Inc.
US ˙ NasdaqCM ˙ US67577C1053

SecurityOCGN / Ocugen, Inc.
InstitutionFmr Llc
Latest Disclosed Ownership0 shares
Ownership 0.00%
Fmr Llc ownership in OCGN / Ocugen, Inc.

2018-10-10 - Fmr Llc has filed an SC 13G/A form with the Securities and Exchange Commission (SEC) disclosing ownership of 0 shares of Ocugen, Inc. (US:OCGN). This represents 0.0 percent ownership of the company. In their previous filing dated 2018-08-10 , Fmr Llc had reported owning 1,633,054 shares, indicating a decrease of -100.00 percent.

Institutional Ownership: 13D/G Filings

This table shows a history of the 13D/G filings made by the investor and/or investor group. Note that the share values in this table are not directly comparable to any numbers shown in the 13F table (if any).

File
Date		Effective
Date		Form Prev
Shares		 Latest
Shares		 ΔShares
(Percent)		 Ownership
(Percent)		 ΔOwnership
(Percent)
2018-10-10 2018-10-10 13G/A 1,633,054 0 -100.00 0.00 -100.00
2018-08-10 2018-08-10 13G/A 1,729,620 1,633,054 -5.58 5.69 -47.57
2017-02-14 2017-02-14 13G/A 1,913,520 1,729,620 -9.61 10.86 -24.69
2016-02-12 2016-02-12 13G/A 1,913,520 14.42
2015-01-12 2015-01-12 13G 1,875,331 14.70

Important Note: One of the primary uses of the 13D/G filings is to evaluate the ability of a firm to control a company (ie, the "beneficial ownership"). To that end, firms are required to report not just direct holdings in companies, but indirect holdings that they control. For investment firms, these indirect holdings can include shares in funds they manage, advisory accounts, and in the case of activist campaigns, pledged votes. Therefore, share counts listed in 13D/G filings can differ significantly than share counts listed in 13F filings.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-15 2026-03-31 13F OCUGEN COM 67577C105 148,674 -2,162 -1.43 269 32.51 0.0000
2026-02-17 2025-12-31 13F OCUGEN COM 67577C105 150,836 -877 -0.58 204 -17.81 0.0000
2025-11-13 2025-09-30 13F OCUGEN COM 67577C105 151,713 -641 -0.42 247 68.03 0.0000
2025-08-14 2025-06-30 13F OCUGEN COM 67577C105 152,354 19,354 14.55 148 58.06 0.0000
2025-05-12 2025-03-31 13F OCUGEN COM 67577C105 133,000 -91,025 -40.63 94 -48.33 0.0000
2025-02-13 2024-12-31 13F OCUGEN COM 67577C105 224,025 94,130 72.47 180 40.63 0.0000
2024-11-13 2024-09-30 13F OCUGEN COM 67577C105 129,895 3,666 2.90 129 -34.36 0.0000
2024-08-13 2024-06-30 13F OCUGEN COM 67577C105 126,229 4,130 3.38 196 -2.50 0.0000
2024-05-13 2024-03-31 13F OCUGEN COM 67577C105 122,099 3,689 3.12 200 194.12 0.0000
2024-02-13 2023-12-31 13F OCUGEN COM 67577C105 118,410 -54,310 -31.44 68 -1.45 0.0000
2023-11-13 2023-09-30 13F OCUGEN COM 67577C105 172,720 149,742 651.68 69 475.00 0.0000
2023-08-11 2023-06-30 13F OCUGEN COM 67577C105 22,978 10,596 85.58 12 20.00 0.0000
2023-08-11 2023-03-31 13F/A-1 OCUGEN COM 67577C105 12,382 9,554 337.84 11 233.33 0.0000
2023-05-11 2023-03-31 13F OCUGEN COM 67577C105 12,382 9,554 11 0.0000
2023-02-13 2022-12-31 13F OCUGEN COM 67577C105 2,828 -442 -13.52 4 -50.00 0.0000
2022-11-10 2022-09-30 13F OCUGEN COM 67577C105 3,270 778 31.22 6 0.00 0.0000
2022-08-12 2022-06-30 13F OCUGEN COM 67577C105 2,492 -8,471 -77.27 6 -83.33 0.0000
2022-05-13 2022-03-31 13F OCUGEN COM 67577C105 10,963 10,661 3,530.13 36 3,500.00 0.0000
2022-02-14 2021-12-31 13F OCUGEN COM 67577C105 302 300 15,000.00 1 0.0000
2022-02-14 2021-09-30 13F/A-1 OCUGEN COM 67577C105 2 -12 -85.71 0 0.0000
2021-11-15 2021-09-30 13F OCUGEN COM 67577C105 2 -12 0 0.0000
2021-08-13 2021-06-30 13F OCUGEN COM 67577C105 14 12 600.00 0 0.0000
2021-05-14 2021-03-31 13F OCUGEN COM 67577C105 2 2 -85.71 0 0.0000
2019-11-13 2019-09-30 13F HISTOGENICS COM 43358V109 0 -2,000 -100.00 0 0.0000
2019-08-13 2019-06-30 13F HISTOGENICS COM 43358V109 2,000 2,000 0 0.0000
2018-11-09 2018-09-30 13F HISTOGENICS COM 43358V109 0 -1,729,620 -100.00 0 -100.00
2018-08-10 2018-06-30 13F HISTOGENICS COM 43358V109 1,729,620 0 0.00 4,324 -9.08 0.0005
2018-05-14 2018-03-31 13F HISTOGENICS COM 43358V109 1,729,620 0 0.00 4,756 34.12 0.0006
2018-02-12 2017-12-31 13F HISTOGENICS COM 43358V109 1,729,620 0 0.00 3,546 3.53 0.0004
2017-11-13 2017-09-30 13F HISTOGENICS COM 43358V109 1,729,620 0 0.00 3,425 10.02 0.0004
2017-08-29 2017-06-30 13F/A-1 HISTOGENICS COM 43358V109 1,729,620 0 0.00 3,113 4.04 0.0004
2017-08-11 2017-06-30 13F HISTOGENICS COM 43358V109 1,729,620 0 3,113
2017-05-11 2017-03-31 13F HISTOGENICS COM 43358V109 1,729,620 0 0.00 2,992 3.60 0.0004
2017-02-10 2016-12-31 13F HISTOGENICS COM 43358V109 1,729,620 0 0.00 2,888 -47.16 0.0004
2016-11-14 2016-09-30 13F HISTOGENICS COM 43358V109 1,729,620 0 0.00 5,466 84.79 0.0007
2016-08-11 2016-06-30 13F HISTOGENICS COM 43358V109 1,729,620 -177,100 -9.29 2,958 -32.25 0.0004
2016-05-16 2016-03-31 13F HISTOGENICS COM 43358V109 1,906,720 -6,800 -0.36 4,366 -34.81 0.0006
2016-02-12 2015-12-31 13F HISTOGENICS COM 43358V109 1,913,520 0 0.00 6,697 -12.29 0.0009
2015-11-10 2015-09-30 13F HISTOGENICS COM 43358V109 1,913,520 0 0.00 7,635 -38.23 0.0011
2015-08-25 2015-06-30 13F/A-1 HISTOGENICS COM 43358V109 1,913,520 0 0.00 12,361 -35.34 0.0016
2015-08-13 2015-06-30 13F HISTOGENICS COM 43358V109 1,913,520 12,361
2015-05-14 2015-03-31 13F HISTOGENICS COM 43358V109 1,913,520 38,189 2.04 19,116 -7.33 0.0024
2015-02-17 2014-12-31 13F HISTOGENICS COM 43358V109 1,875,331 1,875,331 20,629 0.0027
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.